Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
000503.SZ Stock Summary
Top 10 Correlated ETFs
000503.SZ
In the News
000503.SZ Financial details
Company Rating
Neutral
Market Cap
11.05B
Income
-76.5M
Revenue
337.45M
Book val./share
0.69
Cash/share
0.58
Dividend
-
Dividend %
-
Employees
1.62K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2022
P/E
-138.66
Forward P/E
-
PEG
24.3
P/S
33.86
P/B
17.52
P/C
17.26
P/FCF
-88.39
Quick Ratio
1.15
Current Ratio
1.59
Debt / Equity
0.31
LT Debt / Equity
0
-
-
EPS (TTM)
-0.09
EPS next Y
-
EPS next Q
-
EPS this Y
-53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-14.85%
Revenue last 5Y
26.65%
Revenue Q/Q
37.05%
EPS Q/Q
-41.58%
-
-
-
-
SMA20
1.95%
SMA50
-14%
SMA100
1.85%
Inst Own
-
Inst Trans
-
ROA
-7%
ROE
-12%
ROC
-0.13%
Gross Margin
26%
Oper. Margin
-24%
Profit Margin
-23%
Payout
-11%
Shs Outstand
1.04B
Shs Float
731.53M
-
-
-
-
Target Price
-
52W Range
7.67-15.83
52W High
-33.27%
52W Low
+43%
RSI
45.48
Rel Volume
0.45
Avg Volume
19.56M
Volume
8.85M
Perf Week
-10.7%
Perf Month
8.1%
Perf Quarter
-
Perf Half Y
-4.58%
-
-
-
-
Beta
0.763
-
-
Volatility
0.47%, 0.46%
Prev Close
1.11%
Price
10.01
Change
4.27%
000503.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.11 | 0.14 | 0.23 | 0.28 | 0.35 | |
Net income per share | -0.21 | 0.02 | -0.27 | -0.2 | -0.09 | |
Operating cash flow per share | -0.03 | 0.07 | -0.1 | -0.12 | -0.18 | |
Free cash flow per share | -0.07 | 0.04 | -0.12 | -0.14 | -0.22 | |
Cash per share | 0.82 | 0.9 | 1.04 | 0.84 | 0.66 | |
Book value per share | 1.35 | 1.36 | 1.07 | 0.87 | 0.79 | |
Tangible book value per share | 1.12 | 1.15 | 0.91 | 0.72 | 0.62 | |
Share holders equity per share | 1.35 | 1.36 | 1.07 | 0.87 | 0.79 | |
Interest debt per share | 0 | -0.02 | 0.07 | 0.06 | 0.06 | |
Market cap | 13.93B | 15.38B | 7.51B | 15.19B | 9.13B | |
Enterprise value | 13.26B | 14.67B | 7.07B | 14.89B | 9.02B | |
P/E ratio | -74.2 | 882.48 | -30.88 | -85.76 | -108.12 | |
Price to sales ratio | 145.91 | 118.38 | 36.24 | 60.16 | 29.36 | |
POCF ratio | -600.98 | 232.87 | -80.79 | -144.91 | -57 | |
PFCF ratio | -229.46 | 459.09 | -67.87 | -118.72 | -46.15 | |
P/B Ratio | 11.48 | 12.57 | 7.82 | 19.34 | 12.84 | |
PTB ratio | 11.48 | 12.57 | 7.82 | 19.34 | 12.84 | |
EV to sales | 138.88 | 112.9 | 34.08 | 58.95 | 28.99 | |
Enterprise value over EBITDA | -98.79 | 199.38 | -63.8 | -133.04 | -137.26 | |
EV to operating cash flow | -572.01 | 222.09 | -75.99 | -142.02 | -56.29 | |
EV to free cash flow | -218.4 | 437.83 | -63.84 | -116.35 | -45.57 | |
Earnings yield | -0.01 | 0 | -0.03 | -0.01 | -0.01 | |
Free cash flow yield | 0 | 0 | -0.01 | -0.01 | -0.02 | |
Debt to equity | 0 | -0.01 | 0.06 | 0.06 | 0.08 | |
Debt to assets | 0 | -0.01 | 0.05 | 0.04 | 0.05 | |
Net debt to EBITDA | 5 | -9.68 | 4.03 | 2.71 | 1.74 | |
Current ratio | 12.25 | 11.67 | 3.1 | 2.18 | 2 | |
Interest coverage | -854.24K | 115.69 | -231.19 | -53.21 | -55.39 | |
Income quality | 0.12 | 4.26 | 0.38 | 0.59 | 1.9 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | -0.01 | -0.02 | |
Sales general and administrative to revenue | 0.21 | 0.18 | 0.08 | 0.1 | 0.06 | |
Research and developement to revenue | 0.01 | 0.04 | 0.08 | 0.06 | 0.03 | |
Intangibles to total assets | 0.16 | 0.15 | 0.11 | 0.12 | 0.14 | |
Capex to operating cash flow | 1.62 | -0.49 | 0.19 | 0.22 | 0.24 | |
Capex to revenue | -0.39 | -0.25 | -0.09 | -0.09 | -0.12 | |
Capex to depreciation | -1.15 | -1 | -0.55 | -0.64 | -0.95 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0.01 | |
Graham number | 2.52 | 0.77 | 2.55 | 1.97 | 1.29 | |
ROIC | -0.16 | 0.03 | -0.11 | -0.16 | -0.14 | |
Return on tangible assets | -0.17 | 0.02 | -0.21 | -0.17 | -0.09 | |
Graham Net | 0.77 | 0.88 | 0.74 | 0.48 | 0.14 | |
Working capital | 705.98M | 829.27M | 697.79M | 474.17M | 388.06M | |
Tangible asset value | 1.01B | 1.03B | 817.03M | 643.16M | 560.32M | |
Net current asset value | 705.98M | 829.27M | 697.79M | 472.12M | 384.58M | |
Invested capital | 0 | -0.01 | 0.06 | 0.06 | 0.08 | |
Average receivables | 134.18M | 49.76M | 75.42M | 93.73M | 147.3M | |
Average payables | 1.62M | 1.88M | 2.41M | 3.29M | 6.31M | |
Average inventory | 96.42K | 54.17K | 24.24K | 7.76K | -209.97M | |
Days sales outstanding | 95.81 | 209.22 | 134.44 | 160.57 | 215.33 | |
Days payables outstanding | 2.85 | 5.71 | 4.69 | 7.19 | 12.32 | |
Days of inventory on hand | 0.17 | 0.08 | 0.02 | 0.01 | -621.52 | |
Receivables turnover | 3.81 | 1.74 | 2.72 | 2.27 | 1.7 | |
Payables turnover | 128.09 | 63.94 | 77.89 | 50.79 | 29.64 | |
Inventory turnover | 2.21K | 4.3K | 16.91K | 43.28K | -0.59 | |
ROE | -0.15 | 0.01 | -0.25 | -0.23 | -0.12 | |
Capex per share | -0.04 | -0.04 | -0.02 | -0.03 | -0.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.06 | 0.19 | 0.06 | 0.05 | 0.07 | |
Net income per share | -0.05 | 0.04 | -0.05 | -0.05 | -0.03 | |
Operating cash flow per share | -0.05 | 0.04 | -0.05 | -0.04 | -0.05 | |
Free cash flow per share | -0.06 | 0.02 | -0.06 | -0.05 | -0.06 | |
Cash per share | 0.62 | 0.65 | 0.6 | 0.59 | 0.58 | |
Book value per share | 0.76 | 0.78 | 0.74 | 0.7 | 0.69 | |
Tangible book value per share | 0.59 | 0.62 | 0.57 | 0.52 | 0.49 | |
Share holders equity per share | 0.76 | 0.78 | 0.74 | 0.7 | 0.69 | |
Interest debt per share | 0.05 | 0.06 | 0.11 | 0.15 | 0.21 | |
Market cap | 8.19B | 9.21B | 9.8B | 10.78B | 9.44B | |
Enterprise value | 8.08B | 9.1B | 9.78B | 10.8B | 9.54B | |
P/E ratio | -45.96 | 71.9 | -55.83 | -65.57 | -100.05 | |
Price to sales ratio | 157.03 | 52.2 | 175.68 | 242.96 | 155.32 | |
POCF ratio | -183.82 | 287.58 | -223.34 | -338.49 | -229.64 | |
PFCF ratio | -164.07 | 457.82 | -189.08 | -255.73 | -170.32 | |
P/B Ratio | 12.04 | 12.95 | 14.67 | 17.14 | 15.59 | |
PTB ratio | 12.04 | 12.95 | 14.67 | 17.14 | 15.59 | |
EV to sales | 155.04 | 51.55 | 175.37 | 243.51 | 156.87 | |
Enterprise value over EBITDA | -160.75 | 350.77 | -225.72 | -282.84 | -412.24 | |
EV to operating cash flow | -181.49 | 284.01 | -222.94 | -339.26 | -231.94 | |
EV to free cash flow | -161.99 | 452.14 | -188.74 | -256.31 | -172.02 | |
Earnings yield | -0.01 | 0 | 0 | 0 | 0 | |
Free cash flow yield | -0.01 | 0 | -0.01 | 0 | -0.01 | |
Debt to equity | 0.07 | 0.08 | 0.15 | 0.22 | 0.31 | |
Debt to assets | 0.05 | 0.05 | 0.09 | 0.13 | 0.18 | |
Net debt to EBITDA | 2.07 | -4.41 | 0.4 | -0.64 | -4.08 | |
Current ratio | 2.12 | 2 | 1.88 | 1.7 | 1.59 | |
Interest coverage | -90.97 | 60.3 | -61.42 | -40.93 | -15.18 | |
Income quality | 1 | 1 | 1 | 0.77 | 1.74 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | -0.01 | 0.17 | -0.01 | -0.03 | -0.06 | |
Sales general and administrative to revenue | 1.48 | -0.37 | 0.57 | -0.5 | 1.23 | |
Research and developement to revenue | 0.12 | 0.01 | 0.02 | 0 | 0 | |
Intangibles to total assets | 0.15 | 0.14 | 0.15 | 0.15 | 0.16 | |
Capex to operating cash flow | 0.12 | -0.37 | 0.18 | 0.32 | 0.35 | |
Capex to revenue | -0.1 | -0.07 | -0.14 | -0.23 | -0.24 | |
Capex to depreciation | -0.5 | -1.1 | -0.98 | -1.27 | 3.99 | |
Stock based compensation to revenue | -0.06 | 0.01 | 0 | 0.04 | -0.03 | |
Graham number | 0.92 | 0.79 | 0.9 | 0.85 | 0.64 | |
ROIC | -0.06 | 0.04 | -0.06 | -0.06 | -0.03 | |
Return on tangible assets | -0.05 | 0.03 | -0.05 | -0.05 | -0.03 | |
Graham Net | 0.13 | 0.14 | 0.08 | 0.04 | -0.01 | |
Working capital | 362.11M | 388.06M | 343.47M | 296.64M | 262.5M | |
Tangible asset value | 527.1M | 560.32M | 514.82M | 469.82M | 435.76M | |
Net current asset value | 356.75M | 384.58M | 339.37M | 293.96M | 260.32M | |
Invested capital | 0.07 | 0.08 | 0.15 | 0.22 | 0.31 | |
Average receivables | 61.87M | 153.63M | 184.97M | 184.22M | 183.34M | |
Average payables | 2.34M | 5.33M | 6.28M | 3.87M | 3.33M | |
Average inventory | -201.88M | -411.86M | -419.95M | -419.95M | -419.95M | |
Days sales outstanding | 213.58 | 93.56 | 300.87 | 369.3 | 273.4 | |
Days payables outstanding | 3.63 | 8.17 | 6.64 | 6.2 | 5.81 | |
Days of inventory on hand | -626.06 | -412.16 | -656.47 | -746.86 | -769.07 | |
Receivables turnover | 0.42 | 0.96 | 0.3 | 0.24 | 0.33 | |
Payables turnover | 24.8 | 11.02 | 13.55 | 14.52 | 15.49 | |
Inventory turnover | -0.14 | -0.22 | -0.14 | -0.12 | -0.12 | |
ROE | -0.07 | 0.05 | -0.07 | -0.07 | -0.04 | |
Capex per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
000503.SZ Frequently Asked Questions
What is China Reform Health Management and Services Group Co., Ltd. stock symbol ?
China Reform Health Management and Services Group Co., Ltd. is a CN stock and trading under the symbol 000503.SZ
What is China Reform Health Management and Services Group Co., Ltd. stock quote today ?
China Reform Health Management and Services Group Co., Ltd. stock price is $10.01 today.
Is China Reform Health Management and Services Group Co., Ltd. stock public?
Yes, China Reform Health Management and Services Group Co., Ltd. is a publicly traded company.